Quick Answer
BICYCLE THERAPEUTICS PLC reported Earnings Per Share Diluted of $3.16 (loss) per share for the year ending 2025.
- BICYCLE THERAPEUTICS PLC showed a decrease of -9.0% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from BICYCLE THERAPEUTICS PLC's annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2020: $0.67 (loss) per share | Q3 2020: $0.52 (loss) per share | Q1 2021: $0.73 (loss) per share | Q2 2021: $0.74 (loss) per share | Q3 2021: $0.59 (loss) per share | Q1 2022: $0.93 (loss) per share | Q2 2022: $0.90 (loss) per share | Q3 2022: $0.96 (loss) per share | Q1 2023: $1.30 (loss) per share | Q2 2023: $1.41 (loss) per share | Q3 2023: $1.26 (loss) per share | Q1 2024: $0.62 (loss) per share | Q2 2024: $0.77 (loss) per share | Q3 2024: $0.74 (loss) per share | Q1 2025: $0.88 (loss) per share | Q2 2025: $1.14 (loss) per share | Q3 2025: $0.85 (loss) per share.
- Over the full 7 years of available data (2019 to 2025), BICYCLE THERAPEUTICS PLC's Earnings Per Share Diluted has declined by 14.1%.
- Historical annual values: Fiscal year 2025: $3.16 (loss) per share | Fiscal year 2024: $2.90 (loss) per share | Fiscal year 2023: $5.08 (loss) per share | Fiscal year 2022: $3.80 (loss) per share | Fiscal year 2021: $2.67 (loss) per share | Fiscal year 2020: $2.66 (loss) per share | Fiscal year 2019: $2.77 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: